Skip to main content
. 2024 May 9;111(5):znae070. doi: 10.1093/bjs/znae070

Table 9.

Short version: statements pertaining to extra-gastrointestinal manifestations of MUTYH-associated polyposis

Statements Level of evidence and agreement
MAP.EIM.1: No surveillance for extra-intestinal cancers is recommended for MUTYH biallelic carriers. LE: Low
Agreement: 80%
(SA 42%; A 38%; N 13%; SD 7%)

A, agree; D, disagree; LE, level of evidence; N, neutral; SA, strongly agree; SD, strongly disagree.